When was Firefly BioWorks founded?

Firefly BioWorks was founded in 2009.

Where is Firefly BioWorks located?

Firefly BioWorks is headquartered in Cambridge, United States.

Is Firefly BioWorks a funded company?

Firefly BioWorks is a funded company, having raised a total of $3.77M across 7 funding rounds to date. The company's 1st funding round was a $***** Angel round.

When was the latest funding round of Firefly BioWorks?

Firefly BioWorks' latest funding was a $***** Series A round on Jul 21, 2014, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.23B in funding in 2026 to date.

Where does Firefly BioWorks rank among its competitors?

Firefly BioWorks ranks 15th amongst 953 active competitors, of which 61 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of Firefly BioWorks?

Firefly BioWorks' top competitors include Abcam, Meridian Bioscience and Enzo. Among them, BioLamina secured the most recent funding round in April, 2026.

Firefly BioWorks - 2026 Company Profile, Team, Funding & Competitors

Q: Is Firefly BioWorks an acquired company?

Firefly BioWorks got acquired by Abcam on Jan 21, 2015.

Company Details

Firefly BioWorks has developed an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed biological assays on standard laboratory instrumentation. The company’s core technology, Optical Liquid Stamping allows rapid and scalable synthesis of encoded, multi-functional particles for the quantification of biological function. The company’s long-term focus is to provide research and clinical scientists with reliable and affordable solutions for the comprehensive monitoring of biological systems.

Key Metrics

Founded Year

2009

Location

Cambridge, United States

Stage

Acquired

Total Funding

$3.77M in 7 rounds

Latest Funding Round

Series A, Jul 21, 2014, $*****

Investors

PBM Capital & 4 more

Ranked

15^th among 953 active competitors

Similar Companies

Abcam & 1123 more

Exit Details

Acquired by Abcam (Jan 21, 2015)

View Firefly BioWorks' full profile

Firefly BioWorks got acquired by Abcam on Jan 21, 2015 at an acquisition amount of $*****.

Click here to take a look at Firefly BioWorks's acquisition in detail

Firefly BioWorks has raised a total funding of $3.77M over 7 rounds. Firefly BioWorks has 5 institutional investors.

Here is the list of recent funding rounds of Firefly BioWorks:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 21, 2014	4784775	Series A	5659551	1101523	7139263	3719697
Apr 16, 2013	7343014	Grant (prize money)	6207947	9162573	6753734	2020727
May 24, 2012	6497690	Grant (prize money)	2005043	9798822	7804553	Massachusetts Life Sciences Center

Access funding benchmarks and valuations. Sign up today!

View details of Firefly BioWorks's funding rounds and investors

The founders of Firefly BioWorks is Davide M. Marini.

Here are the details of Firefly BioWorks' key team members:

Davide M. Marini: Co-Founder and Chief Executive Officer of Firefly BioWorks.

View details of Firefly BioWorks's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Firefly BioWorks include Abcam, Meridian Bioscience and Enzo. Here is the list of Top 10 competitors of Firefly BioWorks, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
3rd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	65/100
4th	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
5th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
6th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
7th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	58/100
8th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, Europa & 1 others	58/100
9th	BioIVT 1981, Westbury (United States), Acquired	Provider of in vitro diagnostic products and assay services	-	WILsquare Capital, Europa & 4 others	56/100
10th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
15th	Firefly BioWorks 2009, Cambridge (United States), Acquired	Develops platform to allow multiplexed assays on standard laboratory instrumentation	$3.77M	PBM Capital, Breton Capital Ventures & 3 others	54/100